samedan logo

home > pmps > winter 2004 > microbiological environmental monitoring in clean areas: using risk assessment


Dear guest!

article: Microbiological Environmental Monitoring in Clean Areas: Using Risk Assessment
format: Adobe Acrobat PDF file
cost: £


News and Press Releases

BRIM Biotechnology, Inc. Raises $20 Million in Series E Funding Round

Taipei, Taiwan, 1st December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding round. This demonstrates the heightened interest and growing demand for new treatments for Dry Eye Disease (DED). News of this latest funding round comes as BRIM prepares to initiate the Phase 3 clinical trial for its lead asset BRM421 for DED in the US.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement